-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 KiMRqX3AGecSabylOx1DBWvXambOG1sxQ+jNRYyXrwnmXd1/DwGo4izQKdJWmdYs
 LDISc0ch3SSP82kU7I/rjA==

<SEC-DOCUMENT>0001021408-02-000686.txt : 20020413
<SEC-HEADER>0001021408-02-000686.hdr.sgml : 20020413
ACCESSION NUMBER:		0001021408-02-000686
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20020114
ITEM INFORMATION:		Changes in registrant's certifying accountant
ITEM INFORMATION:		Financial statements and exhibits
FILED AS OF DATE:		20020122

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OXIS INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000109657
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				941620407
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08092
		FILM NUMBER:		02513548

	BUSINESS ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217
		BUSINESS PHONE:		5032833911

	MAIL ADDRESS:	
		STREET 1:		6040 N CUTTER CIRCLE STE 317
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DDI PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DIAGNOSTIC DATA INC /DE/
		DATE OF NAME CHANGE:	19850312
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.txt
<DESCRIPTION>FORM 8-K
<TEXT>
<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                -----------------

                                    FORM 8-K

                                 CURRENT REPORT

                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):

                                January 14, 2002

                            OXIS INTERNATIONAL, INC.
             (Exact name of Registrant as specified in its charter)

          Delaware                      0-8092                  94-1620407
(State or other jurisdiction     (Commission File No.)         (IRS Employer
      of incorporation)                                     Identification No.)

            6040 N. Cutter Circle, Suite 317, Portland, Oregon 97217
            (Address of principal executive offices)      (Zip Code)

       Registrant's telephone number, including area code: (503) 283-3911

                                 Not applicable
          (Former name or former address, if changed since last report)


<PAGE>

Item 4. Changes in Registrant's Certifying Accountant

(a)     Effective January 14, 2002, OXIS International, Inc. ("OXIS") dismissed
its prior independent accountant, Deloitte & Touche LLP ("Deloitte"). The
decision to change accountants was approved by the audit committee of OXIS's
Board of Directors.

        Deloitte's independent auditors' report dated March 1, 2001 on OXIS's
consolidated financial statements as of and for the years ended December 31,
2000 and 1999 appearing in OXIS's Annual Report on Form 10-K for the year ended
December 31, 2000 did not contain an adverse opinion or disclaimer of opinion,
nor were they qualified or modified as to uncertainty, audit scope or accounting
principles except for an explanatory paragraph relating to the Company's ability
to continue as a going concern.

        During the audits of OXIS's consolidated financial statements as of and
for the years ended December 31, 2000 and 1999 and through the subsequent
interim periods to the date hereof, there were no disagreements between OXIS and
Deloitte on any matters of accounting principles or practices, financial
statement disclosure, or auditing scope of procedure, which disagreements, if
not resolved to the satisfaction of Deloitte, would have caused it to make a
reference to the subject matter of the disagreements in connection with its
reports.

        OXIS has requested that Deloitte furnish it with a letter addressed to
the Securities and Exchange Commission stating whether or not it agrees with the
above statements. A copy of such letter is being filed as Exhibit 16 to this
Form 8-K.

(b)     Effective January 14, 2002, OXIS engaged King Griffin & Adamson P.C. as
its principal accountant. During the last two fiscal years and the subsequent
interim period to the date hereof, OXIS did not consult King Griffin & Adamson
P.C. regarding any of the matters or events set forth in Item 304(a)(2)(i) and
(ii) of Regulation S-K.

Item 7. Financial Statements and Exhibits.

(c)     Exhibits.

        The following exhibits are filed herewith:

              16. Letter addressed to the Company dated January 16, 2002 from
              Deloitte & Touche LLP to the Securities and Exchange Commission.

                                   SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                             OXIS INTERNATIONAL, INC.
                                             (Registrant)


        Date: January 18, 2002               By:  /s/ Ray R. Rogers
                                                -----------------------------
                                                      Ray R. Rogers
                                                      President

                                       2

<PAGE>

                                  EXHIBIT INDEX

Exhibit No.   Description
- -----------   -----------

16.           Letter addressed to OXIS International, Inc. dated January 16,
              2002 from Deloitte & Touche LLP to the Securities and Exchange
              Commission.

                                       3


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-16
<SEQUENCE>3
<FILENAME>dex16.txt
<DESCRIPTION>LETTER DATED JANUARY 16, 2002
<TEXT>
<PAGE>

                                                                      EXHIBIT 16

January 16, 2002


Securities and Exchange Commission
Mail Stop 11-3
450 Fifth Street, NW
Washington, D.C.  20549

Dear Sirs/Madams:

We have read and agree with the comments in Item 4 of Form 8-K of OXIS
International, Inc. dated January 14, 2002.

Yours truly,



/s/ DELOITTE & TOUCHE LLP

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
